Diagnosis Justification: Chronic Myeloid Leukemia

A 40-year-old male with generalised weakness, weight loss, abdominal discomfort, decreased appetite, massive splenomegaly, anemia (Hb 7.0 g/dL), marked leukocytosis (WBC 90,000/mm³), and thrombocytosis (platelets 8 lakh/mm³) is a classic presentation of Chronic Myeloid Leukemia (CML).

Why Chronic Myeloid Leukemia Fits Best

• Massive splenomegaly: CML is the leukemia most characteristically associated with massive/huge splenomegaly (often the largest spleens seen in any hematologic malignancy), due to extramedullary myeloid proliferation. This is a hallmark clue pointing away from the other options.
• Marked leukocytosis with a middle-aged patient: CML typically presents in the 30–50 year age group (matching this 40-year-old) with a very high WBC count, often driven by neutrophils and their precursors at all stages of maturation (myelocytes, metamyelocytes, band forms) — the classic "leukemic gap-free" myeloid spectrum on peripheral smear.
• Thrombocytosis: An elevated/normal-to-high platelet count (as seen here, 8 lakh/mm³) is a well-recognized feature of CML, reflecting proliferation of the myeloid/megakaryocytic lineage driven by the underlying myeloproliferative process (BCR-ABL1 fusion). This is inconsistent with CLL, where thrombocytopenia (not thrombocytosis) is more typical.
• Anemia: Normocytic anemia is common in CML due to marrow crowding by the expanding granulocytic clone.
• Constitutional symptoms: Weight loss, weakness, decreased appetite, and abdominal discomfort (from splenic enlargement) are typical of the chronic, hypermetabolic proliferative state in CML.

Why the Other Options Are Incorrect

• Chronic Lymphocytic Leukemia (CLL): CLL typically occurs in older patients (>60 years), presents with lymphocytosis (not neutrophilic leukocytosis) and generalised lymphadenopathy is far more prominent than splenomegaly. Thrombocytosis is atypical for CLL — thrombocytopenia is far more common as the disease progresses, making CLL an unlikely fit here.
• Acute Lymphoblastic Leukemia (ALL): ALL is predominantly a disease of children, presents acutely with bone pain, bleeding, and pancytopenia-related symptoms rather than a chronic, indolent course with massive splenomegaly and thrombocytosis.
• Acute Myeloid Leukemia (AML): AML has an acute, rapidly progressive course (days to weeks) with bleeding, infections, and pancytopenia (including thrombocytopenia) due to marrow failure — massive splenomegaly and thrombocytosis are not typical features, unlike the chronic, indolent picture described here.

Conclusion

The combination of a middle-aged patient, massive splenomegaly, marked leukocytosis, anemia, and notably thrombocytosis is most consistent with Chronic Myeloid Leukemia, confirming option 1 as the correct answer.